Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-020101
Filing Date
2018-07-18
Accepted
2018-07-18 17:32:52
Documents
1
Period of Report
2018-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5673
  Complete submission text file 0000899243-18-020101.txt   7389
Mailing Address 1111 BROADWAY 21ST FLOOR OAKLAND CA 94607-4026
Business Address 1111 BROADWAY 21ST FLOOR OAKLAND CA 94607-4026 510-987-9600
REGENTS OF THE UNIVERSITY OF CALIFORNIA (Reporting) CIK: 0000315054 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 0630
Type: 3 | Act: 34 | File No.: 001-38584 | Film No.: 18959089

Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations